1Patrick J. Creaven,Dean E. Brenner,J. Wayne Cowens,Robert P. Huben,Richard M. Wolf,Hiroshi Takita,Susan G. Arbuck,Mohamed S. Razack,April D. Proefrock. A phase I clinical trial of recombinant human tumor necrosis factor given daily for five days[J] 1989,Cancer Chemotherapy and Pharmacology(3):186~191